The healthcare contract research organization market size is expected to reach around US$ 75.9 billion by 2030, growing at a CAGR of 6.2% every year, according to a 2022 study by Precedence Research, the Canada-based market Insight Company.
The base year for the study has been considered 2021, the historic year 2017 and 2020, the forecast period considered is from 2022 to 2030. The healthcare contract research organization market is analyzed on the basis of value (US$ Million), volume (Unit), and price (US$/Unit).
The rising prevalence of various chronic diseases and rapidly growing geriatric population is boosting the demand for the various new and innovative life-saving drugs across the globe. Thus, the rising burden of diseases is fueling the investments by the top pharmaceutical companies in the research & development of various drugs and diagnostic devices, which is driving the growth of the healthcare CRO market.
The specialized research services along with various other services offered by the healthcare CROs such as data management, clinical supply management/project management, medical writing, clinical monitoring, patient & site recruitment, bio-statistics, and regulatory & medical affairs is boosting the demand for the healthcare CRO services. The outsourcing of activities helps the clients to save time and costs, which is a major factor that drive the healthcare CRO market across the globe. During the pandemic in 2020, the healthcare CRO market has witnessed a rapid surge in the revenues as the top pharma companies were heavily investing the research and development of the drugs and vaccines for the COVID-19 disease.
Our Free Sample Reports Includes:
- In-depth Industry Analysis, Introduction, Overview, and COVID-19 Pandemic Outbreak.
- Impact Analysis 180+ Pages Research Report (Including latest research).
- Provide chapter-wise guidance on request 2021 Updated Regional Analysis with Graphical Representation of Trends, Size, & Share, Includes Updated List of figures and tables.
Updated Report Includes Major Market Players with their Sales Volume, Business Strategy and Revenue Analysis by using Precedence Research methodology.
Download a FREE Sample Copy (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1538
Healthcare Contract Research Organization Market Scope
|Market Size||US$ 75.9 Billion by 2030|
|Growth Rate||CAGR of 6.2% from 2022 to 2030|
|Largest Market||North America|
|Fastest Growing Market||Asia Pacific|
|Forecast Period||2022 to 2030|
|Segments Covered||Service, Type, Region|
Healthcare Contract Research Organization Market Report Highlights
- Based on the service, the clinical monitoring segment dominated the global healthcare CRO market in 2020. The presence of specialized and experienced scientists in the CROs and the adoption of advanced and smart analytical tools in the CROs helps to provide specialized and efficient services at a low cost. This is a major factor that drives the growth of the clinical monitoring segment.
- Based on the type, the clinical segment accounted for a market share of around 75% and dominated the market in 2020. This is because a huge cost is involved in the Phase III of the clinical trials, which generates a huge revenue for the healthcare CRO market across the globe.
Healthcare Contract Research Organization Market Regional Snapshot
North America dominated the global healthcare contract research organization market in 2020. The presence of top pharmaceutical companies along with the growing number of CROs in the region has significant contributions in the growth of the market. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), the maximum research and developmental activities occur in US and US also holds the patent and intellectual property rights of the majority of the new developed drugs. The healthcare CRO market is supported by the favorable government regulations and the active participation of the US FDA in the clinical trials and approvals has exponentially driven the growth of the North America healthcare CRO market in the past decade.
On the other hand, Asia Pacific is estimated to be the most opportunistic market during the forecast period. Asia Pacific is known due to the presence of several top healthcare CROs in the countries like India, China, and South Korea. The availability of expert research professionals at cheap costs attracts the pharmaceutical companies to invest in the region. Moreover, the rising burden of diseases is fueling the demand for the drug discovery services of the CROs in the region, which is further expected to drive the growth of the Asia Pacific healthcare CRO market in the forthcoming years.
Read Also: Heating and Cooling Market Reaches US$1,412.2 Bn By 2030
Healthcare Contract Research Organization Market Dynamics
Growing investments in the pharmaceutical research and development activities
Majority of the biopharmaceutical, biosimilar, and medical device companies are investing heavily in the research & development of innovative drugs and medical devices across the globe. The research and development intensive pharmaceutical industry, is heavily investing for the clinical trials, drug discovery, data management, and various other services offered by the CROs to develop new drugs. It is estimated that the global pharmaceutical research and development expenditure increased from around US$135 billion in 2012 to US$185 billion in 2019. Therefore, the increasing investments by the pharmaceutical companies is the most prominent driver of the global healthcare CRO market.
Demand for faster results may hamper the research quality
The healthcare CROs faces extensive pressure to produce desired results from their clients. The costly the research projects and activities may loss its credibility due to the increased pressure of producing results in a short span of time. This may hamper the growth of the market during the forecast period.
Rapidly growing biologics industry
The development of innovative drugs for curing various non-communicable diseases in the biologic industry has gained rapid traction. The rising prevalence of the chronic diseases across the globe is offering the biologics industry a lucrative growth opportunity, which compels them to increasing invest in the research activities and outsource these activities to the specialized healthcare CROs. This is creating a huge growth opportunity for the healthcare CRO market players.
Lack of skilled and experienced professionals
The healthcare CRO industry faces a shortage of skilled and experienced professionals. The recruitment and retention of the skilled scientists in a contract research organization is a major challenge faced by the healthcare CRO market players that has a negative impact on the market.
Healthcare Contract Research Organization Market Key Players
- Charles River Laboratories
- Syneos Health
- Parexel International
- ICON Plc
- Medpace Holdings
- PSI CRO AG
- Axcent Advanced Analytics
- BIO Agile Therapeutics
- Firma Clinical Research
- Acculab Life Sciences
Healthcare Contract Research Organization Market Segmetation
- Data Management
- Clinical Supply Management/Project Management
- Medical Writing
- Clinical Monitoring
- Patient & Site Recruitment
- Regulatory & Medical Affairs
- Investigator Payments
- Quality Management
- Phase I Trial Services
- Phase II Trial Services
- Phase III Trial Services
- Phase IV Trial Services
- Drug Discovery
- Target Validation
- Lead Identification
- Lead Optimization
- North America
- South Korea
- Latin America
- Rest of Latin America
- Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of the Middle East & Africa
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
You can place an order or ask any questions, please feel free to contact at firstname.lastname@example.org | +1 9197 992 333